Profile
Carolyn McAuliffe is currently working as a Senior Director-Communications at Aerie Pharmaceuticals, Inc. since 2021.
Prior to this, she worked as Head-Communications at Masimo Corp.
Carolyn McAuliffe active positions
| Companies | Position | Start |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Public Communications Contact | 2021-09-12 |
Former positions of Carolyn McAuliffe
| Companies | Position | End |
|---|---|---|
| MASIMO CORPORATION | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MASIMO CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Carolyn McAuliffe
